AbCellera Biologics (ABCL) Net Margin (2020 - 2026)
AbCellera Biologics (ABCL) recorded Net Margin of -1368.57% in Q2 2026, down 1165.30 percentage points from -203.27% a year earlier and down 849.45 percentage points from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Net Margin (2020 - 2026) Analysis & Trends
On a TTM basis, AbCellera Biologics' Net Margin came in at -248.83% as of Jun 30, 2026, up 255.08 percentage points year-over-year; for FY2025, it came in at -194.88%, up 369.95 percentage points from FY2024.
- Annual Net Margin has a five-year change of -245.89 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at -564.83% in FY2024 (-179.82 pp), -385.00% in FY2023 (-417.66 pp), 32.66% in FY2022 (-8.25 pp) and 40.90% in FY2021 (-10.10 pp).
- The Q2 2026 figure is the lowest quarterly Net Margin in data going back to Q1 2020.
- On a year-over-year basis, Net Margin rose in four of the last eight quarters, with an average year-over-year change of -85.75 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 657.48 percentage points in Q4 2025, against a drop of 1165.30 percentage points in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -519.12% (Q1 2026), -19.94% (Q4 2025) and -637.84% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 32.99% |
| 10 | AbCellera Biologics | 3.89 Bn | 3.89 Bn | - | -1,368.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,368.57% |
| Mar 31, 2026 | -519.12% |
| Dec 31, 2025 | -19.94% |
| Sep 30, 2025 | -637.84% |
| Jun 30, 2025 | -203.27% |
| Mar 31, 2025 | -1,077.24% |
| Dec 31, 2024 | -677.43% |
| Sep 30, 2024 | -785.42% |
| Jun 30, 2024 | -504.30% |
| Mar 31, 2024 | -407.98% |
| Dec 31, 2023 | -513.67% |
| Sep 30, 2023 | -433.55% |
| Jun 30, 2023 | -303.58% |
| Mar 31, 2023 | -328.99% |
| Dec 31, 2022 | -138.75% |
| Sep 30, 2022 | 26.26% |
| Jun 30, 2022 | -14.78% |
| Mar 31, 2022 | 53.25% |
| Dec 31, 2021 | 43.03% |
| Sep 30, 2021 | -388.16% |
API Access
AbCellera Biologics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();